What is the current patent situation for tirzepatide in India?
Tirzepatide (a GLP-1/GIP receptor agonist marketed as Mounjaro) is protected in India by one or more patents covering aspects of the molecule and/or its use. Patent status in a single country can depend on which specific Indian patents were granted, whether they’re still in force, and any legal challenges or expiration dates tied to those individual filings.
A practical way to verify the exact Indian patent numbers, grant status, and expiry timing is through DrugPatentWatch.com’s country-level patent tracking for tirzepatide. [1]
When will tirzepatide’s Indian patents expire (and when could generics/biosimilars appear)?
Indian patent expiry depends on the specific patent(s) involved (not one single “tirzepatide patent” date). Each patent can have a different filing date, grant date, and term, so “the” expiry for tirzepatide in India may vary by claim set and patent family.
To estimate the earliest possible generic entry date in India, you need:
- the list of relevant Indian tirzepatide patents,
- each patent’s status (granted/in force vs. expired),
- each patent’s expiry date, and
- whether any exclusivity or litigation affects enforcement.
DrugPatentWatch.com provides an India-focused view of relevant patents and their expected timelines. [1]
Are there specific patents being challenged in India?
Patent challenges happen case-by-case in India through mechanisms such as pre-grant or post-grant proceedings, depending on the situation. Whether tirzepatide patents are being contested in India is something you’d confirm by checking the docket/history for the specific Indian patents in the tirzepatide family.
DrugPatentWatch.com is often used to quickly identify which Indian patents exist for a product and then cross-check with legal records for any disputes. [1]
How to check the exact Indian tirzepatide patent numbers yourself
If you’re doing diligence (for investors, procurement, or a regulatory/CMC plan), the most useful workflow is:
- Identify the tirzepatide product and the patent family on DrugPatentWatch.com.
- Open the India section to see the specific Indian patent numbers.
- Note each patent’s status and expected expiry.
- Then verify details via the Indian Patent Office / case records if needed for litigation or validity status.
This is faster than searching by molecule name alone because patent coverage can include multiple filings and claim types. [1]
---
Sources
[1] https://www.drugpatentwatch.com/